Ryan Rader, MD

KU Hem/Onc. Formerly Hem/Onc Fellow @DukeMedicine. @ClevelandClinic Internal Medicine Resident. Passionate about #MedEd, breast cancer, politics and theatre.

[Dr Sarah Sammons @drsarahsam]

Though scientifically promising, PD-1 inhibitors are simply not safe with CDK4/6i. #bcsm

CheckMate7A8= nivo/palbo/AI w grade 3/4 hepatic AEs [n = 3], grade 3 rash and grade 2 immune-mediated pneumonitis [n = 1], grade 3 febrile neutropaenia [n = 1]).
https://t.co/o9aF1VsgzP

[Ryan Rader, MD @RyanRaderMD]

@thriftycars at SFO. 2 hour line to get to the check-in desk to be told they didn’t have a car available right now. Have to wait another 45-60 minutes, already been another hour. Is it reasonable to be waiting 3+ hours for a rental car? Because I don’t think so.

[Dr Sarah Sammons @drsarahsam]

First Line CDK4/6 median PFS and OS to date across trials… #bcsm

[Tahani Atieh @AtiehTahaniDO]

@RyanRaderMD @precisca_

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

New review on Available Systemic Treatments and Emerging Therapies for #BreastCancer Brain Metastases from @RyanRaderMD @CareyAnders1 @nlinmd and @drsarahsam.
👉https://t.co/tXaXAaWugB

[Ryan Rader, MD @RyanRaderMD]

@AtiehTahaniDO @NAbuhadra @NAbuhadra how could you?!

[Ryan Rader, MD @RyanRaderMD]

One of the true treats of in-person conferences is seeing blasts from the past. @NAbuhadra is one of the kindest, hilarious and engaging people. It doesn’t hurt that she’s a brilliant breast oncologist at MSKCC! Thrilled to reconnect, Nour! #ASCO22

[Dr Sarah Sammons @drsarahsam]

@hoperugo discusses Tropics02
Sacituzumab versus Physician Choice chemotherapy in heavily pretreated HR+/HER2- BC.

PFS 5.5 v 4.0 m (HR 0.66)
OS immature

A positive study. Biomarker needed. Trop2 level analysis will be interesting.

#bcsm #ASCO2022 @OncoAlert

[Ryan Rader, MD @RyanRaderMD]

Heading to the airport for my first in-person conference since COVID! #ASCO22 Hoping to learn the latest and greatest, reconnect with old friends.

[Amanda Nizam, MD @AmandaNizamMD]

📣 Heme Onc Fellows searching for jobs in academia, see👇🏼! Sign up to meet with outstanding early career faculty & get invaluable guidance on the job search! Retweet to share w/other fellows! #ASCO22 @dr_simkins @RyanRaderMD @YuWeiChenMD @MadisonConces @LoganRoofMD @KunalDesaiMD

[Ryan Rader, MD @RyanRaderMD]

@ogutierrez89 @elishaPA_C @firstgendocs @LaurenGranat @DulceMariaMPH @medpedshosp @EYMD_ @gyfjiang @JeydithMd @himanshu_deshwa Done

[Jame Abraham, MD, FACP @jamecancerdoc]

Management of the Top 10 Most Common Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy #cancer @oncoalert https://t.co/W5nlbPRShb @ASCO @JCOOP_ASCO

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

A quick snapshot of Her2low #SABCS21

[Paolo Tarantino @PTarantinoMD]

What a ride! Four intense days of presentations, discussions, insights & networking. @SABCSSanAntonio never disappoints.

Here’s my 5 take-home messages from these days.

As usual, these are not exhaustive, as #SABCS21 was truly full of amazing science and striking advancements.

[Halle Moore, MD @HalleMooreMD]

Congratulations ⁦@dbasali⁩ for your #SABCS21 presentation and your ongoing work to better understand disparities in breast cancer outcomes! #CleClinicCancer ⁦@CleClinicMD⁩ ⁦@CCF_IMCHIEFS⁩

[Ryan Rader, MD @RyanRaderMD]

Studies have shown lower risks of GI bleeding on apixaban when compared to rivaroxaban. CVS Caremark is planning to take apixaban off formulary and out of the hands of patients. We should not give patients fewer options. (No conflicts of interest)

[NBCA @StopTheClot]

NBCA has learned the largest pharmacy benefits manager (PBM) in the U.S., CVS Caremark, has made changes to their 2022 commercial formulary which will reduce anticoagulant choices for patients. Learn about what NBCA is doing to advocate for patients: https://t.co/DaQDZRrF3A

[Hope Rugo @hoperugo]

SOFT and TEXT 12-13 yr med FU confirms benefit of EXE+OFS in high risk HER2 neg HR+ BC in premen women. 10% benefit in survival in. <35yo with T/OFS v T and 15% with E/OFS @OncoAlert

[Cleveland Clinic IM @CCF_IMCHIEFS]

She was a senior, he was an intern… and the rest is history. Another CCF power-couple got married this weekend! 👰🏻‍♀️🤵🏼From the wards to the altar, married by one of ours @danielmarcosmd; CCF family celebration! 🍾@BryceMontane @RyanRaderMD @ErinCovert22 @J_YoonYoon

[CNN Breaking News @cnnbrk]

More than 99.99% of fully vaccinated people have not had a breakthrough case of Covid-19 resulting in hospitalization or death, a CNN analysis shows https://t.co/AukcsIjVwq

[Jame Abraham, MD, FACP @jamecancerdoc]

Affordable Care Act and Cancer Survivors' Financial barriers in cancer survivors age 18-64 years significantly improved following ACA implementation https://t.co/TyaGu74NVe @ASCO_pubs @ASCO @OncoAlert